🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

❗️TUMOR EVOLUTION ❗️is critical determinant of: 🔄 temporal and spatial heterogeneity; ↔️ cancer cell - microenvironment interaction; ⏭ resistance to therapies Check out this ESMO - Eur. Oncology #ESMOPerspectives paper by Nicholas McGranahan ow.ly/Ktfz50FEB21

✅OncoTrialsTrack oncotrialstrack.vhio.net/index is a ❗️GREAT❗️ 🆒 tool to find biomarker-guided #clinicaltrial to cancer patients, supported by @EUCANCan_ Vall d’Hebron Institute of Oncology (VHIO). Cristina Viaplana Anna Pedrola Check out this 🆒 article eucancan.com/2021/07/28/onc…

*Quinta é dia de Quintas Moleculares* Implicações terapêuticas de painel hereditário em pacientes com câncer avançado. 19h Brasil *Link de acesso a reunião:* zoom.us/meeting/regist…

Grande honra participar de um #grandround do HCPA UFRGS com uma mesa de experts em Medicina de Precisão! Obrigado pela oportunidade!

Playing with the features of the ⁦ESMO - Eur. Oncology⁩ networking groups 💪 Did you know that you can actively invite your colleagues to these groups to discuss what is going on at #ESMO21 I just invited the fabulous ⁦Rodrigo Dienstmann_MD_MBA⁩ 👇

Recomiendo para quien esta perdido con tantas peliculas en Netflix… estupendo.

👉 Final preps for my talk at ASCO on "Depersonalized Medicine and Genomics: What Are We Missing?" 🔜 Monday, 6th June, 3 pm, Room S102 🤔 WHAT ELSE ARE WE MISSING? Grupo Oncoclínicas Vall d’Hebron Institute of Oncology (VHIO)

Thanks MEDSIR

McKinsey makes $500,000+ on a single presentation. You can learn their simple framework below (for free):

Congratulations Cristina Viaplana Anna Pedrola for the endless effort of keeping OncoTrialsTrack active and up-to-date, a friendly tool for physicians looking for precision oncology trial opportunities through @EUCANCan_ sponsorship!

▶️ Go-to journal for #RWD and #digitalhealth research in oncology! esmorwd.org Flatiron Health @GroupeUnicancer BC Platforms @TriNetX Owkin PromptlyHealth IQVIA GetReal Institute Aetion, Inc. Prostate PIONEER HARMONY Alliance Foundation BD4BO @RWE4Decisions IDEA4RC Project

➡️The future of #RWD research is now! ESMO - Eur. Oncology daily reporter editorial presenting ESMO Real-World Data and Digital Oncology Journal. Proud to be part of this journey❗️ ➡️Go-to journal for health technology innovation in oncology care! dailyreporter.esmo.org/esmo-congress-…

This work represents a milestone for #RWD studies in #oncology ! ➡️ Access ESMO RWD and Digital Oncology content here: esmorwd.org Oncology Advance ESMO - Eur. Oncology

➡️Guidelines for RWD reporting ➡️ChatGPT in medical research ➡️ESMO RWD & Digital Oncology vision and mission esmorwd.org DO NOT MISS THE FIRST ONLINE PAPERS❗️

➡️Future of AI in cancer care The ASCO Post article linking ESMO GROW (#RWD reporting standards) with #AI applied to #oncology and the new ESMO - Eur. Oncology RWD and Digital Oncology Journal Oncology Advance ascopost.com/news/october-2…

Honored with the Brazilian Society of Medical Oncology Prize of Translational Research. Gives me energy to continue fighting for better patient care and outcomes! Thanks ffnava for the continues support! Vall d’Hebron Institute of Oncology (VHIO) Grupo Oncoclínicas

Keynote lecture by Myriam Chalabi at #ESMOGI24 ☑️ is there room for #immunotherapy in MSS colorectal cancer❓

⚠️Do not miss Myriam Chalabi perspective on immunotherapies in MSS #colorectalcancer

#ESMOGI24 day 2 take-home message: 🤔 we cannot assume that young patients with hard-to-treat GI cancers do not deserve discussions on fertility preservation‼️ Excellent closing session

“All disease begins in the gut” #ESMOGI24 ESMO - Eur. Oncology lecture on #microbiome regulating immune system by Laurence Zitvogel